EXECUTIVE ENGAGEMENTS
POOL
582
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
116
Interactions with Platform & by Email
PARTICIPANTS
23
Unique # Participated
VALIDATIONS
9
Responses Validated*
COMPANIES
22
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
302
PAGES
363
EDITION
17
PRICE
USD 5450
CODE
MCP-1831
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13 Billion in the year 2020, is projected to reach a revised size of US$19.2 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Anthrax, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$5.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Smallpox segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
The Biodefense market in the U.S. is estimated at US$3.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
In the global Botulism segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$594.3 Million in the year 2020 will reach a projected size of US$772.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027.
SELECT PLAYERS
Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies
SEGMENTS
» Product (Anthrax, Smallpox, Botulism, Radiation / Nuclear, Other Products)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Biodefense – Global Key Competitors Percentage Market Share in 2020 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2019 & 2027 |
| World Recent Past, Current & Future Analysis for Anthrax by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Anthrax by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Anthrax by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027 |
| World Recent Past, Current & Future Analysis for Smallpox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Smallpox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Smallpox by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027 |
| World Recent Past, Current & Future Analysis for Botulism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Botulism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Botulism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027 |
| World Recent Past, Current & Future Analysis for Radiation / Nuclear by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Radiation / Nuclear by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Radiation / Nuclear by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027 |
| World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027 |
| World Biodefense Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2020 (E) |
| USA Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| USA Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| USA 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Canada Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Canada 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| JAPAN |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2020 (E) |
| Japan Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Japan Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Japan 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| CHINA |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2020 (E) |
| China Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| China Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| China 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| EUROPE |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2020 (E) |
| Europe Recent Past, Current & Future Analysis for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2019 & 2027 |
| Europe Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Europe Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| FRANCE |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2020 (E) |
| France Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| France Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| France 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| GERMANY |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2020 (E) |
| Germany Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Germany Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Germany 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Italy Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Italy 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| UNITED KINGDOM |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2020 (E) |
| UK Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| UK Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| UK 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Rest of Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| ASIA-PACIFIC |
| Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2020 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR |
| Rest of World Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR |
| Rest of World 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 22 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com